טוען...
Update on the Teratogenicity of Maternal Mycophenolate Mofetil
Mycophenolic acid (MPA) products, namely mycophenolate mofetil and mycophenolate sodium, are immunosuppressive medications used to prevent rejection in solid organ transplant recipients and to treat various autoimmune disorders. Mycophenolate therapy is considered to be teratogenic based on observat...
שמור ב:
| הוצא לאור ב: | J Pediatr Genet |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Georg Thieme Verlag KG
2015
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4944211/ https://ncbi.nlm.nih.gov/pubmed/27617117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1556743 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|